257 related articles for article (PubMed ID: 20838951)
1. Novel aspect of ketone action: β-hydroxybutyrate increases brain synthesis of kynurenic acid in vitro.
Chmiel-Perzyńska I; Kloc R; Perzyński A; Rudzki S; Urbańska EM
Neurotox Res; 2011 Jul; 20(1):40-50. PubMed ID: 20838951
[TBL] [Abstract][Full Text] [Related]
2. beta-adrenergic enhancement of brain kynurenic acid production mediated via cAMP-related protein kinase A signaling.
Luchowska E; Kloc R; Olajossy B; Wnuk S; Wielosz M; Owe-Larsson B; Urbanska EM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):519-29. PubMed ID: 19439240
[TBL] [Abstract][Full Text] [Related]
3. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
[TBL] [Abstract][Full Text] [Related]
4. Clenbuterol enhances the production of kynurenic acid in brain cortical slices and glial cultures.
Luchowska E; Kloc R; Wnuk S; Olajossy B; Wielosz M; Urbańska EM
Pharmacol Rep; 2008; 60(4):574-7. PubMed ID: 18799828
[TBL] [Abstract][Full Text] [Related]
5. Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action.
Chmiel-Perzyńska I; Perzyński A; Olajossy B; Gil-Kulik P; Kocki J; Urbańska EM
J Diabetes Res; 2019; 2019():4957879. PubMed ID: 31737685
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by acetoacetate and β-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid.
Thaler S; Choragiewicz TJ; Rejdak R; Fiedorowicz M; Turski WA; Tulidowicz-Bielak M; Zrenner E; Schuettauf F; Zarnowski T
Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1729-35. PubMed ID: 20532550
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors modulate kynurenic acid production in rat brain cortex in vitro.
Zakrocka I; Turski WA; Kocki T
Eur J Pharmacol; 2016 Oct; 789():308-312. PubMed ID: 27423316
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release.
Zmarowski A; Wu HQ; Brooks JM; Potter MC; Pellicciari R; Schwarcz R; Bruno JP
Eur J Neurosci; 2009 Feb; 29(3):529-38. PubMed ID: 19187269
[TBL] [Abstract][Full Text] [Related]
9. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy.
Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J
J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457
[TBL] [Abstract][Full Text] [Related]
10. Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain--in vitro and ex vivo evidence.
Zielińska E; Kuc D; Zgrajka W; Turski WA; Dekundy A
Toxicol Appl Pharmacol; 2009 Oct; 240(2):174-9. PubMed ID: 19616570
[TBL] [Abstract][Full Text] [Related]
11. Ketogenic diet increases concentrations of kynurenic acid in discrete brain structures of young and adult rats.
Żarnowski T; Chorągiewicz T; Tulidowicz-Bielak M; Thaler S; Rejdak R; Żarnowski I; Turski WA; Gasior M
J Neural Transm (Vienna); 2012 Jun; 119(6):679-84. PubMed ID: 22200857
[TBL] [Abstract][Full Text] [Related]
12. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
13. L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II.
Kocki T; Luchowski P; Luchowska E; Wielosz M; Turski WA; Urbanska EM
Neurosci Lett; 2003 Jul; 346(1-2):97-100. PubMed ID: 12850557
[TBL] [Abstract][Full Text] [Related]
14. Influence of Cyclooxygenase-2 Inhibitors on Kynurenic Acid Production in Rat Brain in Vitro.
Zakrocka I; Targowska-Duda KM; Wnorowski A; Kocki T; Jóźwiak K; Turski WA
Neurotox Res; 2019 Jan; 35(1):244-254. PubMed ID: 30178287
[TBL] [Abstract][Full Text] [Related]
15. FK506 attenuates 1-methyl-4-phenylpyridinium- and 3-nitropropionic acid-evoked inhibition of kynurenic acid synthesis in rat cortical slices.
Luchowska E; Luchowski P; Wielosz M; Turski WA; Urbanska EM
Acta Neurobiol Exp (Wars); 2003; 63(2):101-8. PubMed ID: 12926536
[TBL] [Abstract][Full Text] [Related]
16. Age dependency of inhibition of alpha7 nicotinic receptors and tonically active N-methyl-D-aspartate receptors by endogenously produced kynurenic acid in the brain.
Alkondon M; Pereira EF; Eisenberg HM; Kajii Y; Schwarcz R; Albuquerque EX
J Pharmacol Exp Ther; 2011 Jun; 337(3):572-82. PubMed ID: 21270133
[TBL] [Abstract][Full Text] [Related]
17. High Concentration of Ketone Body β-Hydroxybutyrate Modifies Synaptic Vesicle Cycle and Depolarizes Plasma Membrane of Rat Brain Synaptosomes.
Voronina PP; Adamovich KV; Adamovich TV; Dubouskaya TG; Hrynevich SV; Waseem TV; Fedorovich SV
J Mol Neurosci; 2020 Jan; 70(1):112-119. PubMed ID: 31643037
[TBL] [Abstract][Full Text] [Related]
18. Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome.
Baran H; Cairns N; Lubec B; Lubec G
Life Sci; 1996; 58(21):1891-9. PubMed ID: 8637415
[TBL] [Abstract][Full Text] [Related]
19. Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure.
Hilgier W; Kocki T; Obara-Michlewska M; Turski WA; Oja SS; Saransaari P; Albrecht J
Pharmacol Rep; 2014 Jun; 66(3):466-70. PubMed ID: 24905525
[TBL] [Abstract][Full Text] [Related]
20. The effect of three angiotensin-converting enzyme inhibitors on kynurenic acid production in rat kidney in vitro.
Zakrocka I; Kocki T; Turski WA
Pharmacol Rep; 2017 Jun; 69(3):536-541. PubMed ID: 28364692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
